AZACTAM (E.R. Squibb & Sons, L.L.C.)


Welcome to the PulseAid listing for the AZACTAM drug offered from E.R. Squibb & Sons, L.L.C.. This Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: E.R. Squibb & Sons, L.L.C.
NON-PROPRIETARY NAME: AZTREONAM
SUBSTANCE NAME: AZTREONAM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-04-01
END MARKETING DATE: 0000-00-00


AZACTAM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAZACTAM from E.R. Squibb & Sons, L.L.C.
LABELER NAME: E.R. Squibb & Sons, L.L.C.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2010-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0003-2560_a61e1b87-53c7-40d6-b30c-7b00f851e17c
PRODUCT NDC: 0003-2560
APPLICATION NUMBER: NDA050580

Other AZTREONAM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E.R. Squibb & Sons, L.L.C.AZACTAM
Fresenius Kabi USA, LLCAztreonam